Polatuzumab vedotin: Additional Ph Ib/II ROMULUS data

Data from 78 patients with relapsed or refractory diffuse large B cell lymphoma (DLBCL) (n=43) or follicular lymphoma (n=35) in the open-label, international

Read the full 231 word article

User Sign In